Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Five Guidelines for Provider Data Management
This article is the second in a series about provider data quality.
Risk & Insurance
Article
Risk & Insurance: Catastrophic Thinking Derails Injured Worker Recovery; Here's How to Manage It
Delayed recovery is a challenge coming to the forefront of workers' comp.
Mitchell
Article
How Diagnostics Improve the Auto Insurance Claim Process
Fifty years ago all that you needed to fix a dented vehicle was a hammer and dolly. Flash-forward to today.
Workers' Comp
Article
Physician Dispensing and Opioid Abuse: Drug Dilemma Prevention Strategies
When it comes to challenges in workers’ compensation pharmacy, the industry trends are surprisingly similar year after year.
Mitchell
News Release
Physician Dispensing and Opioid Abuse: Drug Dilemma Prevention Strategies
Mitchell
News Release
More States Pass Opioid Prescribing Limit Laws—Congress Also Weighs In
Drug overdose deaths continue to rise. Deaths in 2017, the latest year data is available, reached 70,237, a significant increase over 2016.